Format

Send to

Choose Destination
Infect Agent Cancer. 2016 Apr 27;11:21. doi: 10.1186/s13027-016-0066-9. eCollection 2016.

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners.

Author information

1
Departments of Thoracic & Head and Neck Medical Oncology, Unit 432, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.
2
Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
3
Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
4
Department of Otolaryngology Head/Neck Surgery, The Cancer Center and School of Medicine Stanford University, Stanford, CA 94305 USA.
5
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
6
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.

Abstract

BACKGROUND:

Human papilloma virus (HPV) is a known causative factor in oropharyngeal squamous cell cancer (OPC). In this prospective study, we sought to define the risk of HPV transmission between OPC patients and their sexual partners by performing HPV genotyping on oral cytology brushings.

METHODS:

Newly diagnosed OPC patients and their sexual partners underwent oral mouth swabs and answered a risk factor questionnaire. Patient tumor samples and oral swabs from both the patient and partner were assessed for HPV status and genotyped using Easy-Chip HPV Blot PCR.

RESULTS:

We enrolled 227 patient-partner pairs and obtained sufficient analyzable DNA from both members in 198 pairs. Of 144 patients with available OPC tumor tissue, 128 (89 %) had HPV-positive tumors by either in situ hybridization or p16 immunohistochemical analysis (104 or 121, respectively). In total, there were 28 patients and 30 partners who were HPV positive by oral swab. The prevalence rate of oral HPV in partners was 15 %. There were 39 patient-partner pairs who had one or both members returning positive for HPV in the oral swab, and 49 % of these pairs were concordant for their HPV-genotype. Female partners had a higher oral HPV prevalence (16 %) than did male partners (11 %). Patients who were non-white were also found to have a higher oral prevalence of HPV (p = 0.032) by mouth swab.

CONCLUSIONS:

Partners of OPC patients may have a higher prevalence of oral HPV and should be studied prospectively to understand their OPC risk. Additional future research is needed to identify oral HPV persistence in partners to OPC patients and to determine the optimal sampling methods and technologies to screen patients at high risk for HPV-related disease.

KEYWORDS:

HPV; Oropharyngeal cancer; Partner transmission

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center